Krystal Biotech, Inc. KRYS Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s software and technology licenses, net?
- Krystal Biotech, Inc. (KRYS) reported software and technology licenses, net of $300K in Q1 2026.
- How has Krystal Biotech, Inc.'s software and technology licenses, net changed year-over-year?
- Krystal Biotech, Inc.'s software and technology licenses, net increased by 37.6% year-over-year, from $218K to $300K.
- What is the long-term trend for Krystal Biotech, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s software and technology licenses, net has grown at a -29.2% compound annual growth rate (CAGR), from $1.61M to $287K.